Sanofi SA (ADR) news

   Watch this stock
Showing stories 1 - 10 of about 204   

Articles published

SNY 52.34 +0.67 (1.30%)
price chart
DRug Active runners: Pfizer Inc. (NYSE:PFE), Sanofi SA (ADR) (NYSE:SNY ...
Sanofi SA (ADR) (NYSE:SNY) seems to be in for a bumpy ride. On the one hand there is the imminent patent expiry of Lantus in 2015.
Related articles »  
Can Once Daily GLP-1 Lyxumia Be The Next Major Growth Driver For Sanofi?
Lyxumia (lixisenatide) for the treatment of type 2 diabetes is once-daily GLP-1 from Sanofi's (SNY) stable. It is a potential head to head competitor to Novo Nordisk's (NVO) Victoza ($2.1b - 2013 annual sales).
Sanofi SA (ADR) (NYSE:SNY) In For Interesting Times
Boston, MA, 03/31/2014 (usastockreports)- Sanofi SA (ADR) (NYSE:SNY) seems to be in for a bumpy ride. On the one hand there is the imminent patent expiry of Lantus in 2015.
Stocks in the Spotlight - Edwards Lifesciences Corp(NYSE:EW), Sanofi SA (ADR ...
Sanofi SA (ADR)(NYSE:SNY) recently declared that following constructive discussions with the U.S. Food and Drug Administration (FDA) the company plans to resubmit in the second quarter its supplemental Biologics License Application (sBLA) seeking ...
Sanofi SA (ADR) (NYSE:SNY) Getting Better At The Game
Sanofi SA (ADR) (NYSE:SNY) is a French pharmaceutical company located in Paris, produces drugs that is sold in the prescription drug market.
Notable Movers - Sanofi SA (ADR) (NYSE:SNY), Thermo Fisher Scientific Inc ...
Las Vegas, NV - 07 April 2014 - (Tech Sonian) - Sanofi SA (ADR) (NYSE:SNY) declared that the U.S. Food and Drug Administration (FDA) has expanded the approved age indication of Adacel� (Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular ...
NYSE unusual Volume: Sanofi SA (NYSE:SNY), Hawaiian Electric Industries ...
Sanofi SA (ADR) (NYSE:SNY) seems to be in for a bumpy ride. On the one hand there is the imminent patent expiry of Lantus in 2015.
Healthcare Active runners: Teva Pharmaceutical Industries (NYSE:TEVA ...  Tech News
Related articles »  
Even simple pregnancy tests can run into problems
Providing a superb example of the ever-changing biomedical landscape for even the most mundane of diagnostics, researchers at Washington University School of Medicine find that some commonly-used urine pregnancy tests lose their negative predictive ...
Related articles »  
Notable Stocks: Xenith Bankshares (NASDAQ:XBKS), Sanofi SA (NYSE:SNY ...
Sanofi, formerly Sanofi-Aventis is a global and diversified healthcare company. The Company discovers, develops and distributes therapeutic solutions focused on patients' needs.
Related articles »  
Investor's Alert � Insulet Corporation (NASDAQ:PODD), Hospira, Inc. (NYSE ...
Sanofi SA (ADR) (NYSE:SNY) posted that the U.S. FDA has enlarged the permitted age indication of Adacel (Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed; Tdap) for active booster immunization for the prevention of ...
Related articles »